+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Mycoplasma Testing Market Size, Share & Trends Analysis by Product (Instruments, Kits & Reagents), Technology (PCR, ELISA, Direct Assay, Microbial Culture), Application, End-use, Region, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 120 Pages
  • January 2024
  • Region: Global
  • Grand View Research
  • ID: 4209706
Description Jump to:
The global mycoplasma testing market is expected to reach USD 2.26 billion by 2030, registering a CAGR of 13.58% over the forecast period. The major factors driving the expansion of market includes growing demand for mycoplasma testing in biomanufacturing, emerging economies, and growing pharmaceutical outsourcing. Additionally, the market's overall growth is driven by rising cell-line contamination and innovation & research in biological sciences.

Growing number of government initiatives to support pharmaceutical and biotechnology companies is also driving the market growth. The U.S. FDA proposed to remove a test for detecting mycoplasma within in vitro living cell cultures, as it can help identify only a single test method. These changes in biologics regulations are anticipated to improve specificity and sensitivity in mycoplasma detection tests, leading to introduction of new technologies in the industry. This is expected to create immense opportunities for key players in new product development.

The rates of M. pneumoniae positivity sharply decreased during the COVID-19 pandemic outbreak at the end of 2019. This was a result of the COVID-19 pandemic's stringent regulations, which successfully stopped the spread of M. pneumonia. However, it is anticipated that M. pneumonia will expand even more throughout the research period following the relaxation of COVID-19 limits, which will have a positive impact on the mycoplasma testing market's growth.

Increasing investments in R&D have contributed significantly to the market’s revenue growth. With rising healthcare expenditure, research activities in the life sciences industry are increasing significantly. The adoption of new technologies for drug discovery & development and innovations in cell culture technologies are driving the demand for mycoplasma tests. The high risk of cell culture contamination remains the primary factor expected to drive the mycoplasma testing market over the forecast period

Mycoplasma is estimated to contaminate around 15%-35% of all continuous cell cultures around the world. Out of over 190 known species of mycoplasma, only eight species are responsible for more than 95% of cell culture contamination. Poor cultural practices, aerosols, dust, and cross-contamination as a result of faulty or broken laminar flow are some of the factors responsible for an increase in the number of cell culture contamination events. Such factors are likely to drive the market demand for mycoplasma testing solutions.

Mycoplasma Testing Market Report Highlights

  • By product, kits and reagents dominated the market, and are anticipated to exhibit the fastest CAGR throughout the forecast period, due to their widespread use in mycoplasma testing
  • Ease of conducting the procedure and rapid detection are some of the major advantages offered by the PCR method
  • By application, the cell line testing segment held a largest share of 41.65% in 2023, owing to the increase in research projects being done in the field of cell culture
  • Mycoplasma contamination can cause alterations in cell culture metabolites and lead to development of toxins. This increases the importance of cell line testing and authentication in the pharmaceutical and biopharmaceutical industries
  • North America held the largest share of 39.04% in 2023. This is mostly attributed to the presence of significant market participants, as well as rising R&D spending and federal assistance
  • In Asia-Pacific, the market is expected to grow at the highest rate in a projected time period driven by factors such as the rising prevalence of target diseases with an aging population, rising awareness and others


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Segment Definitions
1.1.1.1 Test Segment
1.1.1.2 Service Provider Segment
1.1.1.3 Application Segment
1.2 Regional Scope
1.3 Estimates and Forecasts Timeline
1.4 Objectives
1.4.1 Objective - 1
1.4.2 Objective - 2
1.4.3 Objective - 3
1.5 Research Methodology
1.6 Information Procurement
1.6.1 Purchased Database
1.6.2 Internal Database
1.6.3 Secondary Sources
1.6.4 Primary Research
1.7 Information Or Data Analysis
1.7.1 Data Analysis Models
1.8 Market Formulation & Validation
1.9 Model Details
1.9.1 Commodity Flow Analysis
1.10 List of Secondary Sources
1.11 List of Abbreviations
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Trends and Outlook
3.4. Market Dynamics
3.4.1. Increasing R&D investments in life sciences
3.4.2. Rising government support toward pharmaceutical and biotechnology industries
3.4.3. Rising cell culture contamination
3.4.4. Growing demand for the introduction of effective treatment of life-threatening diseases
3.4.5. Increased competition in the market
3.5. Market Restraint Analysis
3.5.1. High cost of research in cell biology
3.5.2. Slow rate of mycoplasma growth
3.5.3. Possibility of false negative results
3.6. Business Environment Analysis
3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
3.6.2. Porter’s Five Forces Analysis
3.7. COVID-19 Impact Analysis
Chapter 4. Product Business Analysis
4.1. Mycoplasma Testing Market: Product Movement Analysis
4.2. Instruments
4.2.1. Instruments Market, 2018-2030 (USD Million)
4.3. Kits & Reagents
4.3.1. Kits & Reagents Market, 2018-2030 (USD Million)
4.3.2. PCR Assays
4.3.2.1. PCR Assays Market, 2018-2030 (USD Million)
4.3.3. Nucleic Acid Detection Kits
4.3.3.1. Nucleic Acid Detection Kits Market, 2018-2030 (USD Million)
4.3.4. Stains
4.3.4.1. Stains Market, 2018-2030 (USD Million)
4.3.5. Elimination Kits
4.3.5.1. Elimination Kits Market, 2018-2030 (USD Million)
4.3.6. Standards & Controls
4.3.6.1. Standards & Controls Market, 2018-2030 (USD Million)
4.3.7. Others
4.3.7.1. Others Market, 2018-2030 (USD Million)
4.4. Services
4.4.1. Services Market, 2018-2030 (USD Million
Chapter 5. Technology Business Analysis
5.1. Mycoplasma Testing Market: Technology Movement Analysis
5.2. PCR
5.2.1. PCR Market, 2018-2030 (USD Million)
5.3. ELISA
5.3.1. ELISA Market, 2018-2030 (USD Million)
5.4. Direct Assay
5.4.1. Direct Assay Market, 2018-2030 (USD Million)
5.5. Indirect Assay
5.5.1. Indirect Assay Market, 2018-2030 (USD Million)
5.6. Microbial Culture Techniques
5.6.1. Microbial Culture Techniques Market, 2018-2030 (USD Million)
5.7. Enzymatic Methods
5.7.1. Enzymatic Methods Market, 2018-2030 (USD Million)
Chapter 6. Application Business Analysis
6.1. Mycoplasma Testing Market: Application Movement Analysis
6.2. Cell Line Testing
6.2.1. Cell Line Testing Market, 2018-2030 (USD Million)
6.3. Virus Testing
6.3.1. Virus Testing Market, 2018-2030 (USD Million)
6.4. End of Production Cells Testing
6.4.1. End of Production Cells Testing Market, 2018-2030 (USD Million)
6.5. Others
6.5.1. Others Market, 2018-2030 (USD Million)
Chapter 7. End-use Business Analysis
7.1. Mycoplasma Testing Market: End-use Movement Analysis
7.2. Pharmaceutical & Biotechnology Companies
7.2.1. Pharmaceutical & Biotechnology Companies Market, 2018-2030 (USD Million)
7.3. Cell Banks
7.3.1. Cell Banks Market, 2018-2030 (USD Million)
7.4. Contract Research Organizations
7.4.1. Contract Research Organizations Market, 2018-2030 (USD Million)
7.5. Academic & Research Institutes
7.5.1. Academic & Research Institutes Market, 2018-2030 (USD Million)
7.6. Others
7.6.1. Others Market, 2018-2030 (USD Million)
Chapter 8. Regional Business Analysis
8.1. Mycoplasma Testing Market Share By Region, 2023 & 2030
8.2. North America
8.2.1. SWOT Analysis
8.2.2. North America Mycoplasma Testing Market, 2018-2030 (USD Million)
8.2.3. U.S.
8.2.3.1. Key Country Dynamics
8.2.3.2. Target Disease Prevalence
8.2.3.3. Competitive Scenario
8.2.3.4. Regulatory Framework
8.2.3.5. Reimbursement Scenario
8.2.3.6. U.S. Mycoplasma Testing Market, 2018-2030 (USD Million)
8.2.4. Canada
8.2.4.1. Key Country Dynamics
8.2.4.2. Target Disease Prevalence
8.2.4.3. Competitive Scenario
8.2.4.4. Regulatory Framework
8.2.4.5. Reimbursement Scenario
8.2.4.6. Canada Mycoplasma Testing Market, 2018-2030 (USD Million)
8.3. Europe
8.3.1. SWOT Analysis
8.3.2. Europe Mycoplasma Testing Market, 2018-2030 (USD Million)
8.3.3. Germany
8.3.3.1. Key Country Dynamics
8.3.3.2. Target Disease Prevalence
8.3.3.3. Competitive Scenario
8.3.3.4. Regulatory Framework
8.3.3.5. Reimbursement Scenario
8.3.3.6. Germany Mycoplasma Testing Market, 2018-2030 (USD Million)
8.3.4. UK
8.3.4.1. Key Country Dynamics
8.3.4.2. Target Disease Prevalence
8.3.4.3. Competitive Scenario
8.3.4.4. Regulatory Framework
8.3.4.5. Reimbursement Scenario
8.3.4.6. UK Mycoplasma Testing Market, 2018-2030 (USD Million)
8.3.5. France
8.3.5.1. Key Country Dynamics
8.3.5.2. Target Disease Prevalence
8.3.5.3. Competitive Scenario
8.3.5.4. Regulatory Framework
8.3.5.5. Reimbursement Scenario
8.3.5.6. France Mycoplasma Testing Market, 2018-2030 (USD Million)
8.3.6. Italy
8.3.6.1. Key Country Dynamics
8.3.6.2. Target Disease Prevalence
8.3.6.3. Competitive Scenario
8.3.6.4. Regulatory Framework
8.3.6.5. Reimbursement Scenario
8.3.6.6. Italy Mycoplasma Testing Market, 2018-2030 (USD Million)
8.3.7. Spain
8.3.7.1. Key Country Dynamics
8.3.7.2. Target Disease Prevalence
8.3.7.3. Competitive Scenario
8.3.7.4. Regulatory Framework
8.3.7.5. Reimbursement Scenario
8.3.7.6. Spain Mycoplasma Testing Market, 2018-2030 (USD Million)
8.3.8. Denmark
8.3.8.1. Key Country Dynamics
8.3.8.2. Target Disease Prevalence
8.3.8.3. Competitive Scenario
8.3.8.4. Regulatory Framework
8.3.8.5. Reimbursement Scenario
8.3.8.6. Denmark Mycoplasma Testing Market, 2018-2030 (USD Million)
8.3.9. Sweden
8.3.9.1. Key Country Dynamics
8.3.9.2. Target Disease Prevalence
8.3.9.3. Competitive Scenario
8.3.9.4. Regulatory Framework
8.3.9.5. Reimbursement Scenario
8.3.9.6. Sweden Mycoplasma Testing Market, 2018-2030 (USD Million)
8.3.10. Norway
8.3.10.1. Key Country Dynamics
8.3.10.2. Target Disease Prevalence
8.3.10.3. Competitive Scenario
8.3.10.4. Regulatory Framework
8.3.10.5. Reimbursement Scenario
8.3.10.6. Norway Mycoplasma Testing Market, 2018-2030 (USD Million)
8.3.11. Russia
8.3.11.1. Key Country Dynamics
8.3.11.2. Target Disease Prevalence
8.3.11.3. Competitive Scenario
8.3.11.4. Regulatory Framework
8.3.11.5. Reimbursement Scenario
8.3.11.6. Russia Mycoplasma Testing Market, 2018-2030 (USD Million)
8.4. Asia-Pacific
8.4.1. SWOT Analysis
8.4.2. Asia-Pacific Mycoplasma Testing Market, 2018-2030 (USD Million)
8.4.3. Japan
8.4.3.1. Key Country Dynamics
8.4.3.2. Target Disease Prevalence
8.4.3.3. Competitive Scenario
8.4.3.4. Regulatory Framework
8.4.3.5. Reimbursement Scenario
8.4.3.6. Japan Mycoplasma Testing Market, 2018-2030 (USD Million)
8.4.4. China
8.4.4.1. Key Country Dynamics
8.4.4.2. Target Disease Prevalence
8.4.4.3. Competitive Scenario
8.4.4.4. Regulatory Framework
8.4.4.5. Reimbursement Scenario
8.4.4.6. China Mycoplasma Testing Market, 2018-2030 (USD Million)
8.4.5. India
8.4.5.1. Key Country Dynamics
8.4.5.2. Target Disease Prevalence
8.4.5.3. Competitive Scenario
8.4.5.4. Regulatory Framework
8.4.5.5. Reimbursement Scenario
8.4.5.6. India Mycoplasma Testing Market, 2018-2030 (USD Million)
8.4.6. South Korea
8.4.6.1. Key Country Dynamics
8.4.6.2. Target Disease Prevalence
8.4.6.3. Competitive Scenario
8.4.6.4. Regulatory Framework
8.4.6.5. Reimbursement Scenario
8.4.6.6. South Korea Mycoplasma Testing Market, 2018-2030 (USD Million)
8.4.7. Australia
8.4.7.1. Key Country Dynamics
8.4.7.2. Target Disease Prevalence
8.4.7.3. Competitive Scenario
8.4.7.4. Regulatory Framework
8.4.7.5. Reimbursement Scenario
8.4.7.6. Australia Mycoplasma Testing Market, 2018-2030 (USD Million)
8.4.8. Thailand
8.4.8.1. Key Country Dynamics
8.4.8.2. Target Disease Prevalence
8.4.8.3. Competitive Scenario
8.4.8.4. Regulatory Framework
8.4.8.5. Reimbursement Scenario
8.4.8.6. Thailand Mycoplasma Testing Market, 2018-2030 (USD Million)
8.4.9. Singapore
8.4.9.1. Key Country Dynamics
8.4.9.2. Target Disease Prevalence
8.4.9.3. Competitive Scenario
8.4.9.4. Regulatory Framework
8.4.9.5. Reimbursement Scenario
8.4.9.6. Singapore Mycoplasma Testing Market, 2018-2030 (USD Million)
8.5. Latin America
8.5.1. SWOT Analysis
8.5.2. Latin America Mycoplasma Testing Market, 2018-2030 (USD Million)
8.5.3. Brazil
8.5.3.1. Key Country Dynamics
8.5.3.2. Target Disease Prevalence
8.5.3.3. Competitive Scenario
8.5.3.4. Regulatory Framework
8.5.3.5. Reimbursement Scenario
8.5.3.6. Brazil Mycoplasma Testing Market, 2018-2030 (USD Million)
8.5.4. Mexico
8.5.4.1. Key Country Dynamics
8.5.4.2. Target Disease Prevalence
8.5.4.3. Competitive Scenario
8.5.4.4. Regulatory Framework
8.5.4.5. Reimbursement Scenario
8.5.4.6. Mexico Mycoplasma Testing Market, 2018-2030 (USD Million)
8.5.5. Argentina
8.5.5.1. Key Country Dynamics
8.5.5.2. Target Disease Prevalence
8.5.5.3. Competitive Scenario
8.5.5.4. Regulatory Framework
8.5.5.5. Reimbursement Scenario
8.5.5.6. Argentina Mycoplasma Testing Market, 2018-2030 (USD Million)
8.6. MEA
8.6.1. SWOT Analysis
8.6.2. MEA Mycoplasma Testing Market, 2018-2030 (USD Million)
8.6.3. South Africa
8.6.3.1. Key Country Dynamics
8.6.3.2. Target Disease Prevalence
8.6.3.3. Competitive Scenario
8.6.3.4. Regulatory Framework
8.6.3.5. Reimbursement Scenario
8.6.3.6. South Africa Mycoplasma Testing Market, 2018-2030 (USD Million)
8.6.4. Saudi Arabia
8.6.4.1. Key Country Dynamics
8.6.4.2. Target Disease Prevalence
8.6.4.3. Competitive Scenario
8.6.4.4. Regulatory Framework
8.6.4.5. Reimbursement Scenario
8.6.4.6. Saudi Arabia Mycoplasma Testing Market, 2018-2030 (USD Million)
8.6.5. UAE
8.6.5.1. Key Country Dynamics
8.6.5.2. Target Disease Prevalence
8.6.5.3. Competitive Scenario
8.6.5.4. Regulatory Framework
8.6.5.5. Reimbursement Scenario
8.6.5.6. UAE Mycoplasma Testing Market, 2018-2030 (USD Million)
8.6.6. Kuwait
8.6.6.1. Key Country Dynamics
8.6.6.2. Target Disease Prevalence
8.6.6.3. Competitive Scenario
8.6.6.4. Regulatory Framework
8.6.6.5. Reimbursement Scenario
8.6.6.6. Kuwait Mycoplasma Testing Market, 2018-2030 (USD Million)
Chapter 9. Competitive Landscape
9.1 Company Categorization
9.2 Strategy Mapping
9.2.1 New Product Launch
9.2.2 Partnerships
9.2.3 Acquision
9.2.4 Collaboration
9.2.5 Funding
9.3 Key Company Market Share Analysis, 2023
9.4 Company Profiles
9.4.1 Thermo Fisher Scientific, Inc.
9.4.1.1 Company overview
9.4.1.2 Financial performance
9.4.1.3 Product benchmarking
9.4.1.4 Strategic Initiatives
9.4.2 Merck & Co., Inc.
9.4.2.1 Company overview
9.4.2.2 Financial performance
9.4.2.3 Product benchmarking
9.4.2.4 Strategic Initiatives
9.4.3 Lonza Group AG
9.4.3.1 Company overview
9.4.3.2 Financial performance
9.4.3.3 Product benchmarking
9.4.3.4 Strategic Initiatives
9.4.4 Charles River Laboratories International, Inc.
9.4.4.1 Company overview
9.4.4.2 Product benchmarking
9.4.4.3 Strategic Initiatives
9.4.5 PromoCell GmbH
9.4.5.1 Company overview
9.4.5.2 Financial performance
9.4.5.3 Product benchmarking
9.4.5.4 Strategic Initiatives
9.4.6 Asahi Kasei Medical Co., Ltd.
9.4.6.1 Company overview
9.4.6.2 Financial performance
9.4.6.3 Product benchmarking
9.4.6.4 Strategic Initiatives
9.4.7 Sartorius AG
9.4.7.1 Company overview
9.4.7.2 Financial performance
9.4.7.3 Product benchmarking
9.4.7.4 Strategic Initiatives
9.4.8 InvivoGen
9.4.8.1 Company overview
9.4.8.2 Financial performance
9.4.8.3 Product benchmarking
9.4.8.4 Strategic Initiatives
9.4.9 Eurofins Scientific
9.4.9.1 Company overview
9.4.9.2 Financial performance
9.4.9.3 Product benchmarking
9.4.9.4 Strategic Initiatives
9.4.10 (ATCC) American Type Culture Collection
9.4.10.1 Company overview
9.4.10.2 Financial performance
9.4.10.3 Product benchmarking
9.4.10.4 Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Mycoplasma Testing Market, by Region, 2018-2030 (USD Million)
Table 4 Global Mycoplasma Testing Market, by Product, 2018-2030 (USD Million)
Table 5 Global Mycoplasma Testing Market, by Application, 2018-2030 (USD Million)
Table 6 Global Mycoplasma Testing Market, by Technology, 2018-2030 (USD Million)
Table 7 Global Mycoplasma Testing Market, by End-use, 2018-2030 (USD Million)
Table 8 North America Mycoplasma Testing Market, by Country, 2018-2030 (USD Million)
Table 9 North America Mycoplasma Testing Market, by Product, 2018-2030 (USD Million)
Table 10 North America Mycoplasma Testing Market, by Application, 2018-2030 (USD Million)
Table 11 North America Mycoplasma Testing Market, by Technology, 2018-2030 (USD Million)
Table 12 North America Mycoplasma Testing Market, by End-use, 2018-2030 (USD Million)
Table 13 U.S. Mycoplasma Testing Market, by Product, 2018-2030 (USD Million)
Table 14 U.S. Mycoplasma Testing Market, by Application, 2018-2030 (USD Million)
Table 15 U.S. Mycoplasma Testing Market, by Technology, 2018-2030 (USD Million)
Table 16 U.S. Mycoplasma Testing Market, by End-use, 2018-2030 (USD Million)
Table 17 Canada Mycoplasma Testing Market, by Product, 2018-2030 (USD Million)
Table 18 Canada Mycoplasma Testing Market, by Application, 2018-2030 (USD Million)
Table 19 Canada Mycoplasma Testing Market, by Technology, 2018-2030 (USD Million)
Table 20 Canada Mycoplasma Testing Market, by End-use, 2018-2030 (USD Million)
Table 21 Europe Mycoplasma Testing Market, by Country, 2018-2030 (USD Million)
Table 22 Europe Mycoplasma Testing Market, by Product, 2018-2030 (USD Million)
Table 23 Europe Mycoplasma Testing Market, by Application, 2018-2030 (USD Million)
Table 24 Europe Mycoplasma Testing Market, by Technology, 2018-2030 (USD Million)
Table 25 Europe Mycoplasma Testing Market, by End-use, 2018-2030 (USD Million)
Table 26 Germany Mycoplasma Testing Market, by Product, 2018-2030 (USD Million)
Table 27 Germany Mycoplasma Testing Market, by Application, 2018-2030 (USD Million)
Table 28 Germany Mycoplasma Testing Market, by Technology, 2018-2030 (USD Million)
Table 29 Germany Mycoplasma Testing Market, by End-use, 2018-2030 (USD Million)
Table 30 UK Mycoplasma Testing Market, by Product, 2018-2030 (USD Million)
Table 31 UK Mycoplasma Testing Market, by Application, 2018-2030 (USD Million)
Table 32 UK Mycoplasma Testing Market, by Technology, 2018-2030 (USD Million)
Table 33 UK Mycoplasma Testing Market, by End-use, 2018-2030 (USD Million)
Table 34 France Mycoplasma Testing Market, by Product, 2018-2030 (USD Million)
Table 35 France Mycoplasma Testing Market, by Application, 2018-2030 (USD Million)
Table 36 France Mycoplasma Testing Market, by Technology, 2018-2030 (USD Million)
Table 37 France Mycoplasma Testing Market, by End-use, 2018-2030 (USD Million)
Table 38 Italy Mycoplasma Testing Market, by Product, 2018-2030 (USD Million)
Table 39 Italy Mycoplasma Testing Market, by Application, 2018-2030 (USD Million)
Table 40 Italy Mycoplasma Testing Market, by Technology, 2018-2030 (USD Million)
Table 41 Italy Mycoplasma Testing Market, by End-use, 2018-2030 (USD Million)
Table 42 Spain Mycoplasma Testing Market, by Product, 2018-2030 (USD Million)
Table 43 Spain Mycoplasma Testing Market, by Application, 2018-2030 (USD Million)
Table 44 Spain Mycoplasma Testing Market, by Technology, 2018-2030 (USD Million)
Table 45 Spain Mycoplasma Testing Market, by End-use, 2018-2030 (USD Million)
Table 46 Denmark Mycoplasma Testing Market, by Product, 2018-2030 (USD Million)
Table 47 Denmark Mycoplasma Testing Market, by Application, 2018-2030 (USD Million)
Table 48 Denmark Mycoplasma Testing Market, by Technology, 2018-2030 (USD Million)
Table 49 Denmark Mycoplasma Testing Market, by End-use, 2018-2030 (USD Million)
Table 50 Sweden Mycoplasma Testing Market, by Product, 2018-2030 (USD Million)
Table 51 Sweden Mycoplasma Testing Market, by Application, 2018-2030 (USD Million)
Table 52 Sweden Mycoplasma Testing Market, by Technology, 2018-2030 (USD Million)
Table 53 Sweden Mycoplasma Testing Market, by End-use, 2018-2030 (USD Million)
Table 54 Norway Mycoplasma Testing Market, by Product, 2018-2030 (USD Million)
Table 55 Norway Mycoplasma Testing Market, by Application, 2018-2030 (USD Million)
Table 56 Norway Mycoplasma Testing Market, by Technology, 2018-2030 (USD Million)
Table 57 Norway Mycoplasma Testing Market, by End-use, 2018-2030 (USD Million)
Table 58 Russia Mycoplasma Testing Market, by Product, 2018-2030 (USD Million)
Table 59 Russia Mycoplasma Testing Market, by Application, 2018-2030 (USD Million)
Table 60 Russia Mycoplasma Testing Market, by Technology, 2018-2030 (USD Million)
Table 61 Russia Mycoplasma Testing Market, by End-use, 2018-2030 (USD Million)
Table 62 Asia-Pacific Mycoplasma Testing Market, by Country, 2018-2030 (USD Million)
Table 63 Asia-Pacific Mycoplasma Testing Market, by Product, 2018-2030 (USD Million)
Table 64 Asia-Pacific Mycoplasma Testing Market, by Application, 2018-2030 (USD Million)
Table 65 Asia-Pacific Mycoplasma Testing Market, by Technology, 2018-2030 (USD Million)
Table 66 Asia-Pacific Mycoplasma Testing Market, by End-use, 2018-2030 (USD Million)
Table 67 China Mycoplasma Testing Market, by Product, 2018-2030 (USD Million)
Table 68 China Mycoplasma Testing Market, by Application, 2018-2030 (USD Million)
Table 69 China Mycoplasma Testing Market, by Technology, 2018-2030 (USD Million)
Table 70 China Mycoplasma Testing Market, by End-use, 2018-2030 (USD Million)
Table 71 Japan Mycoplasma Testing Market, by Product, 2018-2030 (USD Million)
Table 72 Japan Mycoplasma Testing Market, by Application, 2018-2030 (USD Million)
Table 73 Japan Mycoplasma Testing Market, by Technology, 2018-2030 (USD Million)
Table 74 Japan Mycoplasma Testing Market, by End-use, 2018-2030 (USD Million)
Table 75 India Mycoplasma Testing Market, by Product, 2018-2030 (USD Million)
Table 76 India Mycoplasma Testing Market, by Application, 2018-2030 (USD Million)
Table 77 India Mycoplasma Testing Market, by Technology, 2018-2030 (USD Million)
Table 78 India Mycoplasma Testing Market, by End-use, 2018-2030 (USD Million)
Table 79 South Korea Mycoplasma Testing Market, by Product, 2018-2030 (USD Million)
Table 80 South Korea Mycoplasma Testing Market, by Application, 2018-2030 (USD Million)
Table 81 South Korea Mycoplasma Testing Market, by Technology, 2018-2030 (USD Million)
Table 82 South Korea Mycoplasma Testing Market, by End-use, 2018-2030 (USD Million)
Table 83 Australia Mycoplasma Testing Market, by Product, 2018-2030 (USD Million)
Table 84 Australia Mycoplasma Testing Market, by Application, 2018-2030 (USD Million)
Table 85 Australia Mycoplasma Testing Market, by Technology, 2018-2030 (USD Million)
Table 86 Australia Mycoplasma Testing Market, by End-use, 2018-2030 (USD Million)
Table 87 Thailand Mycoplasma Testing Market, by Product, 2018-2030 (USD Million)
Table 88 Thailand Mycoplasma Testing Market, by Application, 2018-2030 (USD Million)
Table 89 Thailand Mycoplasma Testing Market, by Technology, 2018-2030 (USD Million)
Table 90 Thailand Mycoplasma Testing Market, by End-use, 2018-2030 (USD Million)
Table 91 Singapore Mycoplasma Testing Market, by Product, 2018-2030 (USD Million)
Table 92 Singapore Mycoplasma Testing Market, by Application, 2018-2030 (USD Million)
Table 93 Singapore Mycoplasma Testing Market, by Technology, 2018-2030 (USD Million)
Table 94 Singapore Mycoplasma Testing Market, by End-use, 2018-2030 (USD Million)
Table 95 Latin America Mycoplasma Testing Market, by Country, 2018-2030 (USD Million)
Table 96 Latin America Mycoplasma Testing Market, by Product, 2018-2030 (USD Million)
Table 97 Latin America Mycoplasma Testing Market, by Application, 2018-2030 (USD Million)
Table 98 Latin America Mycoplasma Testing Market, by Technology, 2018-2030 (USD Million)
Table 99 Latin America Mycoplasma Testing Market, by End-use, 2018-2030 (USD Million)
Table 100 Brazil Mycoplasma Testing Market, by Product, 2018-2030 (USD Million)
Table 101 Brazil Mycoplasma Testing Market, by Application, 2018-2030 (USD Million)
Table 102 Brazil Mycoplasma Testing Market, by Technology, 2018-2030 (USD Million)
Table 103 Brazil Mycoplasma Testing Market, by End-use, 2018-2030 (USD Million)
Table 104 Mexico Mycoplasma Testing Market, by Product, 2018-2030 (USD Million)
Table 105 Mexico Mycoplasma Testing Market, by Application, 2018-2030 (USD Million)
Table 106 Mexico Mycoplasma Testing Market, by Technology, 2018-2030 (USD Million)
Table 107 Mexico Mycoplasma Testing Market, by End-use, 2018-2030 (USD Million)
Table 108 Argentina Mycoplasma Testing Market, by Product, 2018-2030 (USD Million)
Table 109 Argentina Mycoplasma Testing Market, by Application, 2018-2030 (USD Million)
Table 110 Argentina Mycoplasma Testing Market, by Technology, 2018-2030 (USD Million)
Table 111 Argentina Mycoplasma Testing Market, by End-use, 2018-2030 (USD Million)
Table 112 Middle East & Africa Mycoplasma Testing Market, by Country, 2018-2030 (USD Million)
Table 113 Middle East & Africa Mycoplasma Testing Market, by Product, 2018-2030 (USD Million)
Table 114 Middle East & Africa Mycoplasma Testing Market, by Application, 2018-2030 (USD Million)
Table 115 Middle East & Africa Mycoplasma Testing Market, by Technology, 2018-2030 (USD Million)
Table 116 Middle East & Africa Mycoplasma Testing Market, by End-use, 2018-2030 (USD Million)
Table 117 South Africa Mycoplasma Testing Market, by Product, 2018-2030 (USD Million)
Table 118 South Africa Mycoplasma Testing Market, by Application, 2018-2030 (USD Million)
Table 119 South Africa Mycoplasma Testing Market, by Technology, 2018-2030 (USD Million)
Table 120 South Africa Mycoplasma Testing Market, by End-use, 2018-2030 (USD Million)
Table 121 Saudi Arabia Mycoplasma Testing Market, by Product, 2018-2030 (USD Million)
Table 122 Saudi Arabia Mycoplasma Testing Market, by Application, 2018-2030 (USD Million)
Table 123 Saudi Arabia Mycoplasma Testing Market, by Technology, 2018-2030 (USD Million)
Table 124 Saudi Arabia Mycoplasma Testing Market, by End-use, 2018-2030 (USD Million)
Table 125 UAE Mycoplasma Testing Market, by Product, 2018-2030 (USD Million)
Table 126 UAE Mycoplasma Testing Market, by Application, 2018-2030 (USD Million)
Table 127 UAE Mycoplasma Testing Market, by Technology, 2018-2030 (USD Million)
Table 128 UAE Mycoplasma Testing Market, by End-use, 2018-2030 (USD Million)
Table 129 Kuwait Mycoplasma Testing Market, by Product, 2018-2030 (USD Million)
Table 130 Kuwait Mycoplasma Testing Market, by Application, 2018-2030 (USD Million)
Table 131 Kuwait Mycoplasma Testing Market, by Technology, 2018-2030 (USD Million)
Table 132 Kuwait Mycoplasma Testing Market, by End-use, 2018-2030 (USD Million)
List of Figures
Fig. 1 Market Research Process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain-Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 Mycoplasma Testing Market Segmentation
Fig. 8 Market Snapshot, 2023
Fig. 9 Market Trends & Outlook
Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 14 Porter’s Five Forces Analysis
Fig. 15 Global Mycoplasma Testing Market: by Product Movement Analysis
Fig. 16 Global Mycoplasma Testing Market, for Instruments, 2018-2030 (USD Million)
Fig. 17 Global Mycoplasma Testing Market, for Kits & Reagents, 2018-2030 (USD Million)
Fig. 18 Global Mycoplasma Testing Market, for PCR Assays, 2018-2030 (USD Million)
Fig. 19 Global Mycoplasma Testing Market, for Nucleic Acid Detection Kits, 2018-2030 (USD Million)
Fig. 20 Global Mycoplasma Testing Market, for Stains, 2018-2030 (USD Million)
Fig. 21 Global Mycoplasma Testing Market, for Elimination Kits, 2018-2030 (USD Million)
Fig. 22 Global Mycoplasma Testing Market, for Standards & Controls, 2018-2030 (USD Million)
Fig. 23 Global Mycoplasma Testing Market, for Others, 2018-2030 (USD Million)
Fig. 24 Global Mycoplasma Testing Market, for Services, 2018-2030 (USD Million)
Fig. 25 Global Mycoplasma Testing Market: Technology Movement Analysis
Fig. 26 Global Mycoplasma Testing Market, for PCR, 2018-2030 (USD Million)
Fig. 27 Global Mycoplasma Testing Market, for ELISA, 2018-2030 (USD Million)
Fig. 28 Global Mycoplasma Testing Market, for Direct Assay, 2018-2030 (USD Million)
Fig. 29 Global Mycoplasma Testing Market, for Indirect Assay, 2018-2030 (USD Million)
Fig. 30 Global Mycoplasma Testing Market, for Microbial Culture Techniques, 2018-2030 (USD Million)
Fig. 31 Global Mycoplasma Testing Market, for Enzymatic Methods, 2018-2030 (USD Million)
Fig. 32 Global Mycoplasma Testing Market: Application Movement Analysis
Fig. 33 Global Mycoplasma Testing Market, for Cell Line Testing, 2018-2030 (USD Million)
Fig. 34 Global Mycoplasma Testing Market, for Virus Testing, 2018-2030 (USD Million)
Fig. 35 Global Mycoplasma Testing Market, for End of Production Cells Testing, 2018-2030 (USD Million)
Fig. 36 Global Mycoplasma Testing Market, for Other Applications, 2018-2030 (USD Million)
Fig. 37 Global Mycoplasma Testing Market: End-use Movement Analysis
Fig. 38 Global Mycoplasma Testing Market, for Pharmaceutical & Biotechnology Companies, 2018-2030 (USD Million)
Fig. 39 Global Mycoplasma Testing Market, for Cell Banks, 2018-2030 (USD Million)
Fig. 40 Global Mycoplasma Testing Market, for Contract Research Organizations, 2018-2030 (USD Million)
Fig. 41 Global Mycoplasma Testing Market, for Academic & Research Institutes,
Fig. 42 Global Mycoplasma Testing Market, for Others, 2018-2030 (USD Million)
Fig. 43 Regional Marketplace: Key Takeaways Mycoplasma Testing Market, Region 2018-2030 (USD Million)
Fig. 44 Mycoplasma Testing Market :Regional Outlook, 2023 & 2030, 2018-2030 (USD Million)
Fig. 45 North America Mycoplasma Testing Market, 2018-2030 (USD Million)
Fig. 46 U.S. Mycoplasma Testing Market, 2018-2030 (USD Million)
Fig. 47 Canada Mycoplasma Testing Market, 2018-2030 (USD Million)
Fig. 48 Europe Mycoplasma Testing Market, 2018-2030 (USD Million)
Fig. 49 Germany Mycoplasma Testing Market, 2018-2030 (USD Million)
Fig. 50 UK Mycoplasma Testing Market, 2018-2030 (USD Million)
Fig. 51 France Mycoplasma Testing Market, 2018-2030 (USD Million)
Fig. 52 Italy Mycoplasma Testing Market, 2018-2030 (USD Million)
Fig. 53 Spain Mycoplasma Testing Market, 2018-2030 (USD Million)
Fig. 54 Denmark Mycoplasma Testing Market, 2018-2030 (USD Million)
Fig. 55 Sweden Mycoplasma Testing Market, 2018-2030 (USD Million)
Fig. 56 Norway Mycoplasma Testing Market, 2018-2030 (USD Million)
Fig. 57 Russia Mycoplasma Testing Market, 2018-2030 (USD Million)
Fig. 58 Asia-Pacific Mycoplasma Testing Market, 2018-2030 (USD Million)
Fig. 59 Japan Mycoplasma Testing Market, 2018-2030 (USD Million)
Fig. 60 China Mycoplasma Testing Market, 2018-2030 (USD Million)
Fig. 61 India Mycoplasma Testing Market, 2018-2030 (USD Million)
Fig. 62 Australia Mycoplasma Testing Market, 2018-2030 (USD Million)
Fig. 63 South Korea Mycoplasma Testing Market, 2018-2030 (USD Million)
Fig. 64 Thailand Mycoplasma Testing Market, 2018-2030 (USD Million)
Fig. 65 Singapore Mycoplasma Testing Market, 2018-2030 (USD Million)
Fig. 66 Latin America Mycoplasma Testing Market, 2018-2030 (USD Million)
Fig. 67 Brazil Mycoplasma Testing Market, 2018-2030 (USD Million)
Fig. 68 Mexico Mycoplasma Testing Market, 2018-2030 (USD Million)
Fig. 69 Argentina Mycoplasma Testing Market, 2018-2030 (USD Million)
Fig. 70 Middle East and Africa Mycoplasma Testing Market, 2018-2030 (USD Million)
Fig. 71 South Africa Mycoplasma Testing Market, 2018-2030 (USD Million)
Fig. 72 Saudi Arabia Mycoplasma Testing Market, 2018-2030 (USD Million)
Fig. 73 UAE Mycoplasma Testing Market, 2018-2030 (USD Million)
Fig. 74 Kuwait Mycoplasma Testing Market, 2018-2030 (USD Million)

Companies Mentioned

  • Thermo Fisher Scientific, Inc.
  • Merck & Co., Inc.
  • Lonza Group AG
  • Charles River Laboratories International, Inc.
  • PromoCell GmbH
  • Asahi Kasei Medical Co., Ltd.
  • Sartorius AG
  • InvivoGen
  • Eurofins Scientific
(ATCC) American Type Culture Collection

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages120
PublishedJanuary 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 941.1 Million
Forecasted Market Value ( USD ) by 2030 $ 2260 Million
Compound Annual Growth Rate13.5%
Regions CoveredGlobal
No. of Companies Mentioned9

Related Topics

Related Reports

Global Mycoplasma Testing Market by Product & Service (Assays, Kits, & Reagents, Instruments, Services), Technique (Enzyme-Linked Immunosorbent Assay, Nucleic Acid Testing, Staining), Application, End-User - Forecast 2024-2030 - Product Image

Global Mycoplasma Testing Market by Product & Service (Assays, Kits, & Reagents, Instruments, Services), Technique (Enzyme-Linked Immunosorbent Assay, Nucleic Acid Testing, Staining), Application, End-User - Forecast 2024-2030

  • Report
  • 188 Pages
  • Global
From
Mycoplasma Testing Global Market Report 2024 - Product Image

Mycoplasma Testing Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Mycoplasma Testing Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030 - Product Image

Mycoplasma Testing Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030

  • Report
  • 146 Pages
  • Global
From
Mycoplasma Testing - Global Strategic Business Report - Product Image

Mycoplasma Testing - Global Strategic Business Report

  • Report
  • 158 Pages
  • Global
From
Mycoplasma Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 - Product Image

Mycoplasma Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

  • Report
  • 190 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.